Quinazoline compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9168253
APP PUB NO 20130172373A1
SERIAL NO

13807460

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HUTCHISON MEDIPHARMA LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cui, Yumin Shanghai, CN 18 67
Ren, Yongxin Shanghai, CN 14 36
Su, Wei-Guo Shanghai, CN 60 343
Yan, Xiaoqiang Shanghai, CN 43 182
Yang, Haibin Shanghai, CN 13 11
Zhang, Weihan Shanghai, CN 39 93

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 27, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00